Integrichain Blog

Blog

Contracts & Pricing Gary Palgon
December 12, 2018

Looking to 2019 from the Life Sciences Trade and Channel Strategic...

2 Minute Read

In this post IntegriChain Senior Vice President of Sales, Gary Palgon, shares the trending topic's from the 2018 CBI Life Sciences Trade & Channel conference held in Philadelphia, Pa...

Patient Access Brandon Underwood
December 10, 2018

Five Steps to a Better Specialty Pharmacy Data Contracting Strategy

4 Minute Read

An effective specialty data contracting strategy starts at the finish line and works backward. The decisions made in terms of data fields, sub-status granularity, reporting frequency, and contact language,...

Distribution Dave Weiss
September 26, 2018

Frequently Asked Questions – 340B Program

4 Minute Read

The 340B program is subject to increasing scrutiny as pharmaceutical manufacturers search for solutions to identify and act on non-compliance such as diversion and duplicate discounts. This post is...

Channel Shivani Patel
August 20, 2018

Opioid Crisis Exposes Vulnerabilities in Suspicious Order Monitoring

4 Minute Read

The American opioid crisis exposed gaps in the reporting systems designed to flag suspicious orders of pharmaceutical products classified as controlled substances. Pharmaceutical manufacturers are now facing increased scrutiny...

Patient Access Sean McCarthy
August 3, 2018

3 Key Opportunities to Improve Specialty Patient Initiation

3 Minute Read

There are several ways specialty brands can improve patient initiation by implementing data-driven patient support strategies. Successful interventions to streamline patient initiation have the potential to speed Time to...

Managed Services David Carlson
July 27, 2018

The Economics of Rare Disease and Implications for Payer Contract Strategy

3 Minute Read

Rare diseases affect 30 million people in the United States, which roughly equates to 10% of the population. In 2017, 40% of the novel drugs approved by the FDA...

Patient Access Brandon Underwood
March 21, 2017

Specialty Pharmacy Status/Sub-Status Analysis Highlights Inconsistencies in Data Quality

3 Minute Read

Brandon Underwood offers a sneak peek at IntegriChain's upcoming Specialty Analytics benchmark report. IntegriChain examined the quality and granularity of status/sub-status data across 40 specialty pharmacies representing different classes...

Channel Sunay Shah
June 2, 2016

Leveraging Scorecard Analytics to Optimize Changes to DSAs

2 Minute Read

In my last post, I explored how IntegriChain Scorecard Analytics can be used to validate whether the implementation of Distribution Service Agreements (DSAs) drives channel performance. In this post, we will...

Patient Access Colleen Hallett
May 27, 2016

Trends in Specialty Pharmacy Channel Design – Takeaways from Asembia Specialty...

3 Minute Read

The Asembia (formerly known as Armada) Specialty Pharmacy Summit is fast becoming the pharmaceutical industry’s most important meeting. This year’s Las Vegas show boasted a record attendance of nearly...

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand